NCT07165808 Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
| NCT ID | NCT07165808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Nicotine Addiction |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2026-02-13 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2026-02-13 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to assess the effects of nicotine concentration and its interplay with pH on sensory experience, product appeal, and abuse liability of NPs among young adults NP users. Primary objective is to assess the effect of variation in nicotine concentration in nicotine pouches (NPs) and its interaction effect with pH level on three proximal outcomes of relevance to regulation: (1) sensory experience, (2) product appeal, and (3) abuse liability of NPs.
Eligibility Criteria
Inclusion Criteria: * Current established users of nicotine pouches (have used nicotine pouches in the past 30 days \& currently use nicotine pouches every day or someday) * Positive cotinine test via saliva test strip * Those who are unmotivated to quit nicotine use * Read and speak English. * Poly-users of nicotine pouches, e-cigarettes (e.g., vape ≥20 days/month), and tobacco (e.g., ≥4 cigarettes/day for ≥2 years) will be eligible for participation Exclusion Criteria * Planning to cut down or quit using nicotine in the next 30 days * Currently pregnant or breastfeeding * History of stroke, seizures, high blood pressure, heart disease/problems, or cardiovascular disease contraindications for nicotine.
Contact & Investigator
Dae Han, PhD
PRINCIPAL INVESTIGATOR
Rollins School of Public Health
Frequently Asked Questions
Who can join the NCT07165808 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 35 Years, studying Nicotine Addiction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07165808 currently recruiting?
Yes, NCT07165808 is actively recruiting participants. Contact the research team at dae.hee.han@emory.edu for enrollment information.
Where is the NCT07165808 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT07165808 clinical trial?
NCT07165808 is sponsored by Emory University. The principal investigator is Dae Han, PhD at Rollins School of Public Health. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.